Regenerative medicine has become an option that cannot be ignored in the fields of aging, chronic diseases, and conditioning medicine.
Its applications are expanding year by year, including stem cell therapy, PRP therapy, and immune system approaches.
However, we need to think about this calmly.
Regenerative medicine is "medicine" before it is "cutting-edge."
As with any medical procedure, ensuring safety is an absolute requirement, and this cannot be determined solely by technical skill.
Rather, what's important is,
- What kind of facility environment
- What kind of specialists
- Under what management system
- What kind of accountability should be fulfilled?
The question is whether it is being offered.
This article outlines 14 perspectives that patients should objectively consider when evaluating regenerative medicine.
- 1. Whether or not there is a CPC (Cell Processing Facility) within the hospital.
- 2. Cleanroom cleanliness level
- 3. Number of embryologists and their work schedule
- 4. Years of experience as a culture technician
- 5. Continuity of education and training systems
- 6. Collaboration between physicians and embryologists
- 7. Cell preservation methods and timing of administration
- 8. Years of experience and case experience in regenerative medicine.
- 9. Physicians' academic activities and research attitudes
- 10. Establishment of an emergency response system
- 11. In-house study sessions and case sharing
- 12. Level of capital investment
- 13. Quality of Informed Consent
- 14. A calm perspective on excessive advertising.
1. Whether or not there is a CPC (Cell Processing Facility) within the hospital.
In regenerative medicine, which deals with cells, the existence of a **CPC (Cell Processing Center)** is indispensable.
There are two main types of CPC.
- Outsourced type
- On-site type
Having an in-house CPC (Cell Processing Center) offers the advantage of being able to manage the entire process from cell collection and processing to administration.
On the other hand, even if the work is outsourced, there is no problem as long as a strict management system is in place.
The important thing is to be clear about "where," "who," and "under what kind of control" the cells are being handled.
2. Cleanroom cleanliness level
In CPC (Cleaning Process Control), cleanliness is managed based on the number of airborne particles.
Generally,
- Class 10,000
- Class 1,000
- Class 100
There are classifications like these.
The higher the level of cleanliness, the lower the risk of microbial contamination of cells.
However, not just the numbers,Can that environment be maintained stably?That is also important.
Meeting the standards and maintaining a high level are two different things.
3. Number of embryologists and their work schedule
Cell culture is a delicate process.
It requires concentration and often involves prolonged periods of tension.
In environments with insufficient personnel, the risk of human error naturally increases.
A minimum of three people is desirable, but ideally, a surplus of staff and a shift system should be in place.
The number of people is the foundation of safety.
4. Years of experience as a culture technician
Cell culture is not just a technique.
The ability to perceive subtle changes in temperature, time, and cells is honed through accumulated experience.
The experience level of team leaders and the average experience level of the entire team directly impact the consistency of quality.
The field of regenerative medicine is relatively new, and there is a global shortage of skilled personnel.
That's why experience is an important indicator.
5. Continuity of education and training systems
Regenerative medicine is evolving at a rapid pace.
Yesterday's standard is not today's cutting edge.
Participation in public training, internal training, education by external lecturers, case conferences, etc.
Does a culture of continuous learning exist?This indicates the maturity level of the organization.
What's important isn't just attending a one-off seminar, but whether it's a system that's firmly established.
6. Collaboration between physicians and embryologists
When cell processing and clinical administration are physically and structurally separated,
There is a possibility of discrepancies in information transmission.
Who describes the state of the cells, and how are they being handed over?
Is in-person verification being conducted?
Regenerative medicine is a field that lies at the boundary between "manufacturing" and "medicine."
That's why interdepartmental collaboration is crucial to safety.
7. Cell preservation methods and timing of administration
Should it be frozen for storage, or administered immediately without freezing?
Freezing has the advantage of providing flexibility in transportation,
There are risks of damage and handling associated with the thawing process.
While non-frozen administration is sometimes considered superior in terms of quality preservation,
Consequently, a self-contained system within the facility is required.
What's important is not the superiority or inferiority of the methods,
Can you clearly explain the risks and benefits of each?That is the case.
8. Years of experience and case experience in regenerative medicine.
Regenerative medicine is not a panacea.
The criteria for determining suitability, dosage, and monitoring progress are refined through the accumulation of case experience.
The number of years of service provision, the number of cases, and the target areas can serve as reference points for assessing safety.
9. Physicians' academic activities and research attitudes
Medicine is constantly evolving.
Membership in related academic societies, research presentations, paper submissions, and academic society activities are all included.
This demonstrates access to and a critical approach to verifying the latest knowledge.
In the field of regenerative medicine, the ability to interpret evidence is particularly crucial.
10. Establishment of an emergency response system
No matter how much we strive for safety, there is never zero risk in medicine.
Anaphylaxis response protocol,
Stockpiling of emergency medications,
Cardiopulmonary resuscitation training,
Collaboration with nearby core hospitals.
What's important is whether these are not just formalities, but systems that actually function.
11. In-house study sessions and case sharing
The quality of healthcare is supported not only by individual capabilities but also by a learning culture throughout the organization.
Multidisciplinary conferences and case reviews are
This is key to preventing errors and improving quality.
12. Level of capital investment
Regenerative medicine is highly dependent on equipment.
CPC performance, cell testing equipment, monitoring devices, backup power supply, etc.
Investing in unseen aspects supports safety.
13. Quality of Informed Consent
A medical approach that focuses solely on "effectiveness" is not yet mature.
Are risks, limitations, individual differences, and potential contraindications explained?
Is it documented in writing?
Transparency is a prerequisite for trust.
14. A calm perspective on excessive advertising.
Regenerative medicine is a form of medicine that offers hope.
but,
"We will definitely improve."
"Fundamental treatment"
"No side effects"
We need to be cautious about making such definitive statements.
The ability to discuss the balance between possibilities and reality is an indicator of a mature healthcare institution.
Look at the system, not the technology.
Regenerative medicine is a symbol of the future of medicine.
However, its safety cannot be measured by glamorous photos of the facilities or advertising copy.
What you should really see is,
- Management system
- Quality of personnel
- organizational culture
- Accountability
That is the case.
Choosing the future also means choosing the environment.
If you are considering regenerative medicine,
I want to understand the "system" that lies beyond that technology.
That is how one should approach mature healthcare.
Comment